scholarly journals Factors Affecting Sick Leave Duration for Non-Work-Related Temporary Disabilities in Brazilian University Public Servants

2018 ◽  
Vol 15 (10) ◽  
pp. 2127 ◽  
Author(s):  
Adriano Dias ◽  
Juan Gómez-Salgado ◽  
João Bernardes ◽  
Carlos Ruiz-Frutos
Keyword(s):  
Sick Leave ◽  
Depressive Disorders ◽  
Cox Regression ◽  
Insulin Dependent Diabetes Mellitus ◽  
Dependent Diabetes Mellitus ◽  
Historical Cohort ◽  
Sickness Absenteeism ◽  
Factors Affecting ◽  
Work Related

Sickness absenteeism in public institutions compromises the execution of services, and may also generate direct impacts on the population that receives coverage. To determine if sick leave duration for temporary disabilities is associated with non-work-related illnesses (NWRI), a historical cohort study was carried out of workers at a Brazilian University. The Charlson Comorbidity Index (CCI) was obtained from the most prevalent diagnoses in each expert examination and from the corresponding days of sick leave per episode, adjusting simple and multiple Cox regression models. As a result, 70% of the NWRI temporary disabilities were due to depressive disorders, convalescence, and dorsalgia with a sick leave duration between 4 and 320 days. The factors of protection for sick leave durations until the rehabilitation were non-insulin-dependent diabetes mellitus and hypertension. Long-term sick leaves were observed in the cases that required rehabilitation of those workers diagnosed with recurrent depressive disorders, conjunctivitis, acute sinusitis, skin disorders, calculus of kidney and ureter, abdominal and pelvic pain, and same-level fall accidents. It is also worth noting that even in a disease that can justify long-term sick leaves, such as breast cancer, the duration may be shorter according to the worker’s capacity and self-efficacy.

scholarly journals P.2.07 Times of sick leave due to temporary disability related to a non-work-related illness and re-adaptation to work

2019 ◽  
Vol 76 (Suppl 1) ◽  
pp. A89.1-A89
Author(s):  
Adriano Dias ◽  
João Marcos Bernardes ◽  
Juan Gomez-Salgado ◽  
Carlos Ruiz-Frutos
Keyword(s):  
Back Pain ◽  
Sick Leave ◽  
Vocational Rehabilitation ◽  
Protective Factor ◽  
Depressive Disorders ◽  
Upper Airways ◽  
Historical Cohort ◽  
Work Related ◽  
The Times

ObjectiveTo evaluate if the times of sick leave due to temporary disability related to a non-work-related illness (NWRI) depends on whether or not the workers have required a vocational rehabilitation.MethodHistorical cohort study of university workers in São Paulo, Brazil, between 2010 and 2015. Data were obtained from work institutional databases that recorded personal, occupation, physician’s examination and vocational rehabilitation data. The Charlson Comorbidity Index was obtained from medical history according to the most prevalent diagnoses in each physician’s assessment report and respective sick leave episode duration. Associations between variables were analyzed by simple and multiple Cox regression models.ResultsDepressive disorders, convalescences and back pain were responsible for 70% of all sick leaves due to non-work-related conditions that caused temporary disability. Follow-up time was decreased when the number of NWRI per worker increases, follow-up times until readaptation between 4 and 320 days and great variability within the same disease. The CCI weight was of 0 in 96.2% of sick leaves. In the Cox model, the number of physician’s examinations (HR=0.96), non-insulin-dependent diabetes mellitus (HR=0.40) and primary essential hypertension (HR=0.29) were found to be significant protective factor for sick leave duration until vocational rehabilitation. Recurrent depressive disorders (HR=1.5), conjunctivitis (HR=2.78), acute sinusitis (HR=4.99), skin conditions (HR=3, 80), back pain (HR=1.62), kidney and ureter calculus (HR=2.31), pelvic abdominal pain (HR=2.33) and falls at the same level (HR=3.71) were risk factors to longer sick leave duration until vocational rehabilitation.ConclusionWhen there was more medical assessment during the period of sick leave the times were reduced and some diseases such as upper airways, eyes and skin, pain and depression require longer times until vocational rehabilitation.

scholarly journals Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study

2020 ◽  
Vol 39 (9) ◽  
pp. 2583-2592
Author(s):  
Frank Behrens ◽  
Hans-Peter Tony ◽  
Michaela Koehm ◽  
Eva C. Schwaneck ◽  
Holger Gnann ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Sick Leave ◽  
Disease Activity ◽  
Work Productivity ◽  
Work Outcomes ◽  
Work Related ◽  
Adalimumab Therapy ◽  
Adalimumab Treatment ◽  
Observational Cohort

Abstract Objective The goal of this study was to evaluate the long-term impact of adalimumab therapy on work-related outcomes in employed patients with rheumatoid arthritis (RA). Method We utilized data from an observational cohort of German patients who initiated adalimumab treatment during routine clinical care. Analyses were based on employed patients (part-time or full-time) who continued adalimumab treatment for 24 months. Major outcomes were self-reported sick leave days in the previous 6 months, absenteeism, presenteeism, and total work productivity impairment as assessed by the Work Productivity and Activity Impairment (WPAI) questionnaire and disease activity assessments. The normal number of sick leave days was based on data from the German Federal Statistical Office. Results Of 783 patients, 72.3% were women, mean age was 47.9 years, and mean disease duration was 7.8 years. At baseline (before adalimumab initiation), 42.9% of patients had higher than normal sick leave days (> 5) in the previous 6 months. During 24 months of adalimumab treatment, 61% of patients with higher than normal sick leave days at baseline returned to normal sick leave values (≤ 5 days/6 months). Overall, mean sick leave days/6 months decreased from 14.8 days at baseline to 7.4 days at month 24. Improvements were observed in WPAI assessments and disease activity measures, although presenteeism levels remained high (32.2% at month 24). Conclusions Adalimumab treatment was associated with strong and sustained improvements in work-related outcomes in employed patients who continued on adalimumab for 24 months. Presenteeism appears to be the work outcome most resistant to improvement during RA treatment. Trial registration NCT01076205 Key Points• Long-term adalimumab therapy was associated with sustained improvements in work outcomes in patients with rheumatoid arthritis.• Despite improvements in sick leave days and work absenteeism, presenteeism (impairment while at work) remained relatively high.

Sign in / Sign up

Export Citation Format

Share Document